148 results
Keyword Docetaxel Remove keyword
-
List item
Press release: Mylan S.A.S. withdraws its marketing authorisation application for Docetaxel Mylan (docetaxel)
Last updated: 15/03/2010authorisation application for Docetaxel Mylan docetaxel … authorisation application for Docetaxel Mylan docetaxel … authorisation cision to withdraw Docetaxel Mylan The medicine was … -
List item
Press release: Sanofi-Aventis Pharma S.A. withdraws its application for an extension of indication for Taxotere and Docetaxel Winthrop (docetaxel)
Last updated: 17/11/2008indication for Taxotere and Docetaxel Winthrop docetaxel … indication for Taxotere and Docetaxel Winthrop docetaxel … indication for Taxotere and Docetaxel Winthrop docetaxel) The European Medicines … -
List item
Press release: EMA reviewing cancer medicine docetaxel
PRAC, Last updated: 10/03/2017EMA reviewing cancer medicine docetaxel … EMA reviewing cancer medicine docetaxel … reviewing cancer medicine docetaxel 30 Churchill Place … -
List item
Press release: PRAC concludes there is no evidence of a change in known risk of neutropenic enterocolitis with docetaxel
PRAC, Last updated: 09/06/2017neutropenic enterocolitis with docetaxel … neutropenic enterocolitis with docetaxel … neutropenic enterocolitis with docetaxel 30 Churchill Place … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 September 2019
CHMP, Last updated: 20/09/2019Bavencio, Benlysta, Docetaxel Zentiva, Dupixent, Lucentis … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 June 2017
PRAC, Last updated: 09/06/2017hearing; concludes review of docetaxel … -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 March 2017
PRAC, Last updated: 10/03/2017also started the review of docetaxel-containing medicines in the context … -
List item
Press release: New treatment option for patients with advanced lung cancer
CHMP, Last updated: 22/05/2015receive either nivolumab or docetaxel (a commonly used type of … overall survival compared with docetaxel (median 9.2 months compared … of patients treated with docetaxel. Nivolumab BMS' recommendation … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 March 2012
CHMP, Last updated: 16/03/2012PDF icon application/pdf Docetaxel Accord docetaxel Accord Healthcare Ltd PDF … PDF icon application/pdf Docetaxel Kabi docetaxel Fresenius Kabi Oncology Plc … -
List item
Press release: European Medicines Agency completes its review of Avastin used in breast cancer
CHMP, Last updated: 16/12/2010Avastin in combination with docetaxel is negative and that this … Avastin in combination with docetaxel may have a negative impact … Combination therapy of Avastin and docetaxel for metastatic breast cancer … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 June 2016
CHMP, Last updated: 24/06/2016Docetaxel Sun … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 February 2011
CHMP, Last updated: 18/02/2011authorisation of the generic docetaxel-containing medicine … authorisation of the generic docetaxel- containing medicine Docetaxel Teva Generics, from Teva … bioequivalence studies with Docetaxel Teva Generics had not been … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 June 2015
CHMP, Last updated: 26/06/2015Docetaxel Hospira UK Limited … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 November 2012
CHMP, Last updated: 16/11/2012progressed on or after a docetaxel-based chemotherapy regimen. More … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 November 2011
CHMP, Last updated: 18/11/2011PDF icon application/pdf Docetaxel Mylan docetaxel Mylan S.A.S … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 28-30 April 2020
CHMP, Last updated: 30/04/2020previously treated with a docetaxel-containing regimen. Hybrid applications … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use,21-24 July 2008
CHMP, Last updated: 25/07/2008authorisation for Taxotere / Docetaxel Winthrop (PDF/36.96 KB … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP), 18-21 October 2010
CHMP, Last updated: 22/10/2010Docetaxel Teva Pharma … generic of Hycamtin. • Docetaxel Teva Pharma docetaxel), from Teva Pharma B.V … metastatic prostate cancer. Docetaxel Teva Pharma is a generic … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP), 17-20 May 2010
CHMP, Last updated: 21/05/2010Docetaxel Winthrop … inhibitor. • Taxotere and Docetaxel Winthrop docetaxel), from Aventis Pharma S.A … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP), 16-19 November 2009
CHMP, Last updated: 20/11/2009Docetaxel TEVA … of generic medicines: Docetaxel TEVA docetaxel), from Teva Pharma B.V … information for Taxotere (docetaxel) and Docetaxel Winthrop … -
List item
Press release: European Medicines Agency statement on Herceptin
CHMP, Last updated: 22/09/2005Herceptin in combination with docetaxel for the treatment of patients … Herceptin in combination with docetaxel for the treatment of patients … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 January 2011
CHMP, Last updated: 21/01/2011previously treated with a docetaxel-containing regimen. The review for Jevtana … previously treated with a docetaxel-containing regimen. The review for Jevtana … -
List item
Press release: European Medicines Agency: Committee for Medicinal Products for Human Use 13-16 September 2004
Last updated: 16/09/2004docetaxel), Aventis, to extend its … June 2002. Taxotere (docetaxel), Aventis, to extend its … -
List item
Press release: Meeting highlights from the Committee for Medicinal Products for Human Use, 18-21 September 2006
CHMP, Last updated: 21/09/2006cardiovascular diseases: Taxotere (docetaxel), from Aventis Pharma S.A … cardiovascular diseases: Taxotere (docetaxel), from Aventis Pharma S.A … -
List item
Press release: European Medicines Agency: Committee for Medicinal Products for Human Use 20-23 March 2006
CHMP, Last updated: 24/03/2006docetaxel), from Aventis Pharma S.A … epilepsy. § Taxotere (docetaxel), from Aventis Pharma S.A …